Treace Medical Appoints Two New Members to its Board of Directors

Treace Medical Concepts, Inc., a privately-held medical device company focused on advancing the standard of care for hallux valgus (bunion) surgery, announced today that its Board of Directors has appointed John K. Bakewell and Lawrence W. Hamilton as members of the Board.

“John and Lawrence bring valuable expertise and perspective as we propel our novel approach to bunion deformity correction further into the market and position the Company for its next phase of growth,” said James T. Treace, Chairman of the Board. “We are very pleased to welcome them to our Board and look forward to working closely with them as we continue to grow Treace Medical.”

John K. Bakewell has served in senior executive roles for nearly three decades, building and executing business strategies for growth companies across the medical device, specialty pharma, diagnostics and healthcare provider sectors, while also serving on public- and private-company boards. Mr. Bakewell’s professional experience in the medical technology industry includes serving for nine years as Executive Vice President and Chief Financial Officer of Wright Medical Group, Inc., from its private equity-backed reorganization through the company’s initial public offering, as well as multiple years of industry-leading growth and creation of its industry-leading lower extremities franchise.

“I’m excited to be joining the Board of Treace Medical, with its disruptive Lapiplasty® system that treats the root cause of the bunion deformity,” said Mr. Bakewell. “The company has made important inroads with its surgeon and patient educational programs, addressing a large, unmet need due to significant limitations of current surgical treatments. I look forward to working with the Treace Medical team as it continues to scale up its commercial operations and supportive infrastructure.”

Lawrence W. Hamilton was most recently Senior Vice President, Human Resources-Worldwide and member of the Executive Committee at Tech Data Corporation in Clearwater, FL, a technology distributor with over 11,000 associates worldwide. Since 2008, he has served as a Senior Adjunct Faculty and Executive Coach with the Center for Creative Leadership affiliate Leadership Development Institute at Eckerd College, St. Petersburg, FL. He also manages a private executive coaching and HR consulting practice, Hamilton Consulting. Mr. Hamilton has served in a variety of human resource management and executive level positions, with several publicly-traded companies including the Bristol-Myers Squibb Company.

“I am impressed with Treace Medical’s focus in building an organization that is aligned with its goal to advance the standard of care in bunion surgery,” said Mr. Hamilton. “I look forward to contributing to initiatives for successful market conversion as the company strategically expands its footprint.”

The appointment of Mr. Bakewell and Mr. Hamilton increases the number of Treace Medical Board of Directors to 8 members.

About Treace Medical Concepts

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion Correction™ system is designed to reproducibly correct all three planes of the bunion deformity and address the root cause of the bunion, while allowing patients to get back to their active lives quickly. To learn more about Lapiplasty® 3D Bunion Correction™, or find a Lapiplasty® surgeon in your area, please visit: www.AlignMyToe.com or www.treace.com/patients.

This communication may contain forward-looking statements about the Company, within the general meaning of the term. Such forward-looking statements, by their nature, are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those in the forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201120005723/en/